French v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided February 28, 2017·No. 14-383·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 14-383V Filed: January 30, 2017

* * * * * * * * * * * * * ANGIE F. FRENCH and DAN FRENCH, * on behalf of V.F, a minor child, * * Petitioners, * Special Master Sanders * v. * Decision on Stipulation; Diphtheria Tetanus * Acellular Pertussis (“DTaP”) Vaccine; SECRETARY OF HEALTH * Haemophilus Influenza Type B (“Hib”) AND HUMAN SERVICES, * Vaccine; Acute Liver Failure; Autoimmune * Hepatitis Type 2. Respondent. * * * * * * * * * * * * * * Glynn W. Gilcrease, Jr., Law Office of Glynn W. Gilcrease, Jr., PC, Tempe, AZ, for Petitioner. Althea Walker Davis, United States Department of Justice, Washington, DC, for Respondent.

DECISION1

On May 6, 2014, Angie F. French and Dan French (“Petitioners”) filed a petition for compensation pursuant to the National Vaccine Injury Compensation Program,2 42 U.S.C. §§ 300aa-1 to -34 (2012), on behalf of their minor child, V.F. Petitioners alleged that, as a result of diphtheria, tetanus, and acellular pertussis (“DTaP”) and Haemophilus influenza type b (“Hib”) vaccines administered on January 15, 2013, V.F. developed acute liver failure and autoimmune hepatitis type 2 on or about February 9, 2013. See Stipulation for Award at ¶ ¶ 1-4, filed Jan. 30, 2017. Petitioners further alleged that V.F. suffered residual effects of these injuries for more than six months. Id. at ¶ 4.

1 Because this decision contains a reasoned explanation for the undersigned’s action in this case, the undersigned intends to post this decision on the website of the United States Court of Federal Claims, in accordance with the E-Government Act of 2002, codified as amended at 44 U.S.C. § 3501 note (2012). As provided by Vaccine Rule 18(b), each party has 14 days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012) (“Vaccine Act” or “the Act”). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. 1 On January 30, 2017, the parties filed a stipulation in which they state that a decision should be entered awarding compensation to Petitioner. Id. at ¶ 7. Respondent denies that the DTaP or Hib vaccines caused Petitioners’ acute liver failure and autoimmune hepatitis type 2, or any other injury. Id. at ¶ 6. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein.

The parties stipulate that Petitioner shall receive the following compensation:

A. A lump sum payment of $2,500.00, in the form of a check payable to petitioners, Angie F. French and Dan French, for past unreimbursable expenses;

B. A lump sum of $60,000.00 in the form of a check payable to petitioners, as guardians/conservators of V.F.’s estate; and

C. An amount sufficient to purchase the annuity contract described in paragraph 10 [of Appendix A], paid to the life insurance company from which the annuity will be purchased (the “Life Insurance Company”).

Id. at ¶ 8.

The undersigned approves the requested amount for Petitioner’s compensation. Accordingly, an award should be made consistent with the stipulation.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the clerk of the court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3

IT IS SO ORDERED.

s/Herbrina D. Sanders Herbrina D. Sanders Special Master

3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS

ANGIE F. FRENCH and DAN FRENCH, ) on behalf of V.F ., a minor child, ) ) Petitioner, ) No. 14-383V ) Special Master v. ) Lisa Hamilton-Fieldman ) SECRETARY OF HEALTII ) AND HUMAN SERVICES, ) ) Respondent. ) ~~~~~~~~~)

STIPULATION

The parties hereby stipulate to the following matters:

_l. On behalf of their daughter, V.F., petitioners filed a petition for vaccine

compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §

300aa-l 0 to 34 (the ''Vaccine Program"). The petition seeks compensation for injuries

allegedly related to V.F.' s receipt of the diphtheria, tetanus and acellular pertussis

("DTaP',) and Haemophilus influenzae type b ("Hib") vaccines, which vaccines are

contained in the Vaccine Injury Table (the "Table"), 42 C.F.R. § 100.3 (a).

2. V.F. received DTaP and Hib immunizations on January 15, 2013.

3. The vaccines were administered within the United States. 4. Petitioners alleges that V.F. sustained the first symptom or manifestation of the

onset of acute liver failure and autoimmune hepatitis type 2 on or about February 9, 2013.

Petitioners further allege that V.F. will require life-long immunosuppression and that she

suffered the residual effects of this injury for more than six months.

1 5. Petitioners represent that there has been no prior award or settlement of a civil

action for damages on V. F.,s behalf as a result of her condition.

6. Respondent denies that the DTaP and Hib vaccines caused V.F. 's acute liver

failure and autoimmune hepatitis type 2 or any other injury or her cutTent disabilities.

7. Maintaining their above-state~ positions, the parties nevertheless now agree

that the issues between them shall be settled and that a decision should be entered

awarding the compensation described in paragraph 8 of this Stipulation.

8. As soon as practicable after an entry of judgment reflecting a decision

consistent with the ~1ms of this Stipulation, and after petitioners have filed an election to

receive compensation pmsuant to 42 U.S.C. § 300aa-2 l (a)(l ), the Secretary of Health

and Human Services will issue the following vaccine compensation payments:

(a) A lump sum payment of $2,500.00, in the fo1m of a check payable to petitioners, Angie F. ~rench and Dan French, for past unreimbursable expenses;

(b) A lump sum of $60,000.00, in the form of a check payable to petitioners, as guardians/conservators ofV.F.'s estate; and

(c) An amount sufficient to purchase the annuity contract described in paragraph 10 below, paid to the life insurance company from which the annuity will be purchased (the "Life Insurance Company").

9. The Life Insurance Company must have a minimum of $250,000,000 capital

and surplus, exclusive of any mandatory security valuation reserve. The Life Insurance

Company must have one of the following ratings from two of the following rating

organizations:

a. A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s;

b.

Free access — add to your briefcase to read the full text and ask questions with AI

French v. Secretary of Health and Human Services, (uscfc 2017).

French v. Secretary of Health and Human Services (French v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 300aa
42 U.S.C. § 300aa
§ 300aa-
42 U.S.C. § 300aa-
§ 300aa-1
42 U.S.C. § 300aa-1
§ 300aa-10
42 U.S.C. § 300aa-10
§ 300aa-15
42 U.S.C. § 300aa-15(a)
§ 300aa-2
42 U.S.C. § 300aa-2
§ 300aa-l
42 U.S.C. § 300aa-l
Purposes
44 U.S.C. § 3501
§ 300a
42 U.S.C. § 300a